GIRK4 inhibitor | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19,901 results for “GIRK4 inhibitor”

Trials

View all 9770 →

Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor

43 participants · First posted Jun 7, 2017

TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma

33 participants · First posted Sep 26, 2017

Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform

First posted Jul 21, 2014

Drugs

View all 4063 →

TYK2 inhibitor

Fascin Inhibitor

BRAF-inhibitor+EGFR-inhibitor+ bromodomain-inhibitor (colorectal cancer)

Organizations

View all 20 →

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

News

View all 6048 →

Bayer Launches Global Phase II Trial of GIRK4 Inhibitor BAY 3670549 in Atrial Fibrillation

Bayer and Broad Institute Extend Cardiovascular Research Partnership Through 2030

Atrial Fibrillation Pipeline Shows Robust Development with 15+ Novel Therapies from Leading Pharmaceutical Companies

Page 1 of 1991